Skip to content

ABEONA THERAPEUTICS INC.

ABEO

CIK 0000318306

← back to feed
Revenue (TTM)
$13.62M
+66.3% YoY Q1 May 2026
Net Income (TTM)
$74.57M
+211.7% YoY Q1 May 2026
EPS Diluted (TTM)
$1.07
+165.2% YoY Q1 May 2026
Gross Margin
88.8%
Q1 May 2026
Operating Margin
-657.6%
Q1 May 2026
Net Margin
547.5%
Q1 May 2026
Free Cash Flow (TTM)
−$67.77M
Q1 May 2026
Cash
$61.37M
Q1 May 2026
Total Debt
$4.75M
Q1 May 2026
Shares Outstanding
57M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings